Co-Diagnostics, Inc. Reports Second Quarter 2022 Financial Results
Second quarter results impacted by volume declines; Further progress on the development of the Co-Dx PCR Home platformSALT LAKE CITY, Aug. 11, 202...
Stay updated with breaking news from Dwight Egan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Second quarter results impacted by volume declines; Further progress on the development of the Co-Dx PCR Home platformSALT LAKE CITY, Aug. 11, 202...
Canntab Therapeutics Ltd said it has appointed Richard Goldstein, currently the company's chief financial officer (CFO), as its interim chief executive...
/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...
Canntab Therapeutics Ltd said it has appointed Richard Goldstein, currently the company's chief financial officer (CFO), as its interim chief executive...
/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...